After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$255.93K

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 4, 2026
Public filing date Jun 5, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$547.69 Jun 4, 2026
First close after public filing
$544.69 Jun 8, 2026
30-day return after filing
+0.47% Through Jul 6, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
473 shares @ $541.08
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000070
Filing cohort

Transactions in this filing

Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.58M
Buys / sales
0 / 11
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 4, 2026 $1.39M
United Therapeutics Corp UTHR Current Sale Jun 4, 2026 $255.93K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $60.76K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $215.07K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $800.04K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $646.59K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $918.89K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $428.41K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $308.26K
United Therapeutics Corp UTHR Exercise Jun 4, 2026 $0
United Therapeutics Corp UTHR Sale Jun 4, 2026 $64.74K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $656.46K
United Therapeutics Corp UTHR Sale Jun 4, 2026 $834.98K